First Manhattan’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-286
Closed -$6K 1334
2020
Q3
$6K Buy
+286
New +$6.85K ﹤0.01% 1171

Other funds holding BTAL

First Manhattan's BTAL Position: Q4 2020 in Review

First Manhattan sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2020, closing a stake of 286 shares — an estimated $6K sold.

First Manhattan first reported a position in BTAL in Q3 2020 and held it in 1 quarter. The position peaked at $6K in Q3 2020. 36 funds tracked by Wall St. Rank hold BTAL as of Q4 2020.

  • First Manhattan reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2020 after selling out during the quarter.
  • First Manhattan sold 286 AGF US Market Neutral Anti-Beta Fund shares in Q4 2020, an estimated $6K.
  • First Manhattan first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2020 and held it in 1 quarter.
  • First Manhattan's AGF US Market Neutral Anti-Beta Fund position peaked at $6K in Q3 2020.
  • 36 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2020.

Based on First Manhattan's 13F filing for Q4 2020, filed 16 Feb 2021.